Here we review your favorite and most-read pieces from all five of our partnered journals in 2018, giving you access to the most popular articles over the last year.
Search Results: bough (10)
Three novel radiopharmaceuticals have been evaluated for their potential to be utilized in PET imaging of tau proteins in humans. The results of the study have the potential to improve the way we diagnose and treat Alzheimer’s disease.
A team of researchers have devised a novel method of diagnosing autism in children. Following analysis of short home videos of children, mathematical modelling was utilized to provide a numerical score indicating the severity of the developmental disorder.
A combination of CBL0137 and panobinostat has been demonstrated to effectively treat neuroblastoma in mice. This combination therapy has the potential to lead the fight against this aggressive childhood cancer.
SfN18: Can animal models offer an insight into human opioid addiction, withdrawal and relapse behaviors?
New studies in which animal models have been utilized to study opioid addiction, withdrawal and relapse may offer insights into managing the opioid epidemic in humans.
An international team of researchers have determined that there are no benefits to exposing patients’ brains to hypothermic conditions following traumatic brain injury.
Researchers from Tufts University have developed 3D human tissue culture models for the CNS. This may facilitate the discovery of new treatment methods for neurodegenerative diseases.
Chinese tech firm Tencent and British healthcare technology company Medopad are joining forces to develop an artificial intelligence model with the ability to assess motor function in patients with Parkinson’s disease.
Scientists at The Wellcome Sanger Institute have determined that the risk of suffering from a range of monogenic neurodevelopmental genetic disorders can be affected by common genetic variations.
Neurology and neuroscience are fast-moving, multidisciplinary fields at the forefront of medical and scientific progression.…